Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryla
Recalled April 17, 2024 · FDA recall D-0437-2024 · Lupin Pharmaceuticals
Hazard
Subpotent Drug · FDA Class II
Units
26,352 bottles
Sold at
Nationwide within the United States
Description
Subpotent Drug
Product
Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India, NDC 6818-0659-06
Manufacturer(s)
Lupin Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →